The Inflammation Biomarker GlycA Reflects Plasma N-Glycan Branching
Clinical Chemistry · 2023
DOI: 10.1093/clinchem/hvac160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Chemistry, 2023. Verfasst von Maxence Noel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, National Center for Functional Glycomics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Inflammation. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIA NIH HHS, NCEH CDC HHS.
Abstract (Originalsprache)
Background
GlycA is a nuclear magnetic resonance (NMR) signal in plasma that correlates with inflammation and cardiovascular outcomes in large data sets. The signal is thought to originate from N-acetylglucosamine (GlcNAc) residues of branched plasma N-glycans, though direct experimental evidence is limited. Trace element concentrations affect plasma glycosylation patterns and may thereby also influence GlycA.
Methods
NMR GlycA signal was measured in plasma samples from 87 individuals and correlated with MALDI-MS N-glycomics and trace element analysis. We further evaluated the genetic association with GlycA at rs13107325, a single nucleotide polymorphism resulting in a missense variant within SLC39A8, a manganese transporter that influences N-glycan branching, both in our samples and existing genome-wide association studies data from 22 835 participants in the Women’s Health Study (WHS).
Results
GlycA signal was correlated with both N-glycan branching (r2 ranging from 0.125–0.265; all P < 0.001) and copper concentration (r2 = 0.348, P < 0.0001). In addition, GlycA levels were associated with rs13107325 genotype in the WHS (β [standard error of the mean] = −4.66 [1.2674], P = 0.0002).
Conclusions
These results provide the first direct experimental evidence linking the GlycA NMR signal to N-glycan branching commonly associated with acute phase reactive proteins involved in inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery, National Center for Functional Glycomics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
- Preventive Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
- Center for Lipid Metabolomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
- Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
- Laboratory Corporation of America Holdings, Morrisville, NC, USA.
- New York State Department of Health, Laboratory of Inorganic and Nuclear Chemistry, Wadsworth Center, Albany, NY, USA.
ORCID-Profile: Daniel I Chasman, Samia Mora, Richard D Cummings, Robert G Mealer
Förderung
- NHLBI NIH HHS
- NIA NIH HHS
- NCEH CDC HHS
- NCI NIH HHS
- NIMH NIH HHS
- NIH HHS
- NIGMS NIH HHS
- FDA HHS
Zitieren
APA
Noel, M., Chasman, D. I., Mora, S., Otvos, J. D., Palmer, C. D., Parsons, P. J., Smoller, J. W., Cummings, R. D., & Mealer, R. G. (2023). The Inflammation Biomarker GlycA Reflects Plasma N-Glycan Branching. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvac160
Vancouver
Noel M, Chasman DI, Mora S, Otvos JD, Palmer CD, Parsons PJ, et al. The Inflammation Biomarker GlycA Reflects Plasma N-Glycan Branching. Clinical Chemistry. 2023. doi:10.1093/clinchem/hvac160
BibTeX
@article{Noel2023,
author = {Noel, Maxence and Chasman, Daniel I and Mora, Samia and Otvos, James D and Palmer, Christopher D and Parsons, Patrick J and Smoller, Jordan W and Cummings, Richard D and Mealer, Robert G},
title = {The Inflammation Biomarker GlycA Reflects Plasma N-Glycan Branching},
journal = {Clinical Chemistry},
year = {2023},
doi = {10.1093/clinchem/hvac160}
}
EUVIMED